Skip to content

Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy

Non Invasive Assessment of Liver Fibrosis in Children: Evaluation of Diagnostic Performances of ShearWave Elastography (SWE) and Fibrotest®/ Fibromax® by Comparison With Fibrosis Score on Liver Biopsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02041780
Acronym
SHEARWAVE
Enrollment
220
Registered
2014-01-22
Start date
2013-11-30
Completion date
2016-05-31
Last updated
2016-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Liver Fibrosis

Keywords

Diagnostic, Liver fibrosis, Ishak score, Fibrotest, ShearWave elastography, Liver biopsies

Brief summary

The purpose of this study is to determine if SWE and Fibrotest®/ Fibromax®, alone or associated, are effective methods to assess liver fibrosis in children.

Detailed description

Liver biopsy will be the gold standard to assess fibrosis using Ishak score and morphometric evaluation of fibrosis. All children included will have a measure of liver stiffness using SWE with 5 measures performed in the area where the biopsy is performed and 5 measures in an other place in the liver. Fibrotest®/ Fibromax® will be performed on blood sample. All exams will be done within 1 month. diagnostic performance of SWE and Fibrotest®/ Fibromax® will be assessed respectively. algorithm using the results of both technics will be tested in order to test diagnostic performance and to obtain better performances.

Interventions

PROCEDUREShearwave electrography

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* age \< 18 years; * indication to liver biopsy; * informed consent of both parents and child if applicable; * social insurance

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
liver fibrosis evaluated by the ISHAK score and morphometric evaluationup to 1 monthHistology is the gold standard to evaluate liver fibrosis

Secondary

MeasureTime frame
liver fibrosis evaluation : stiffness using SHEARWAVE elastographyup 1 month
Liver fibrosis evaluation using Fibrotest (Fibromax)up 1 month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026